HURN— AI Stock Forecast & Price Targets
Published 6/30/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live HURN price forecast →
HURN presents a mixed picture: strong recent operational news (record revenue, AI expansion) contrasts with significant valuation concerns and historical price weakness. The technicals show consolidation near key support levels, while analyst sentiment is cautiously optimistic based on recent contract wins. We recommend an ACCUMULATE approach, awaiting confirmation of upward momentum above immediate resistance.
ACCUMULATE on dips toward established support levels, specifically monitoring the $90-$95 range seen in the 1d chart. A decisive break and hold above the recent resistance cluster (near $120-$130) would signal immediate upside confirmation.
The thesis hinges on HURN successfully monetizing its AI/Healthcare expansion pipeline, leading to sustained double-digit revenue growth that justifies current valuation multiples. Expected return range is contingent on achieving analyst consensus targets ($155 mentioned), suggesting a potential move toward the $130-$160 area over 6 months.
The long-term driver remains its diversified consulting portfolio across Healthcare, Education, and Commercial sectors. The biggest structural risk is maintaining high growth rates while servicing significant debt loads; sustained profitability improvements are required to de-risk the balance sheet.
The company demonstrates solid operational health with record revenue reported in Q1 2026 ($443.7M, up 12.1% YoY) and strong profitability metrics (Operating Margin of 9.26%). The balance sheet appears stable, though the Debt-to-Equity ratio at 223.87 suggests significant leverage that requires monitoring against future cash flow generation. Free Cash Flow has been volatile, swinging from negative in Q1 2026 to positive in prior quarters, indicating variable capital expenditure management. Overall, revenue growth and strategic acquisitions (like RelateCare) are strong drivers, but the high debt load is a structural concern.
The price action across both timeframes suggests a pattern of consolidation following significant drops, with the 1d chart showing recent support holding near $95.55. The yellow forecast band on the 1w chart shows the current price ($95.55) is trading below the historical range and appears to be testing key support levels established during prior uptrends. While momentum has been choppy, the failure to break decisively above immediate resistance suggests caution; however, the model's high bullish probability (1.0 on 1d) should be viewed skeptically given the recent volatility.
The most positive signals are derived from operational news: HURN posted record revenue in Q1 2026 and is actively expanding its AI-led healthcare managed services via acquisitions like RelateCare, which strengthens its core consulting mix. Analyst coverage remains mixed; while one firm lowered a price target to $155 (Benzinga), the overall narrative points to underlying strength despite past declines. The news flow suggests management is executing on growth initiatives rather than facing immediate headwinds.
- Expansion into AI-enabled healthcare managed services through strategic acquisitions like RelateCare deepens their service offering in patient access and care coordination.
- High leverage indicated by a Debt-to-Equity ratio of 223.87, making the stock sensitive to interest rate hikes or operational slowdowns.
- The historical price action shows significant drawdowns (e.g., dropping 48.4% mentioned in news), indicating high volatility and potential for sharp reversals.
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord